Skip to main content

Nonprofit · EIN 91-1935159

FRED HUTCHINSON CANCER CENTER

Tax-exempt · SEATTLE, WA 98109

Financials

$2.3B$2B2022$2B$2.1B2023$2.5B$2.4B2024
Revenue Expenses · by fiscal year end
Financials of FRED HUTCHINSON CANCER CENTER by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
June 30, 2025990$2,532,392,907$2,405,985,717$126,407,190$3,600,753,073$2,033,708,861$1,567,044,212
June 30, 2024990$2,027,046,671$2,064,743,953-$37,697,282$3,453,149,919$1,995,980,709$1,457,169,210
June 30, 2023990$2,322,795,971$1,951,660,593$371,135,378$3,407,176,412$2,024,301,434$1,382,874,978
Financial details: 990 for the year ended June 30, 2025

Revenue

Contributions, gifts and grants
$705,214,753
of which government grants
$404,404,170
Program service revenue
$1,650,922,336
Investment income
$137,731,829
Royalties
$20,468,284
Net rental income
$9,132,204
Net gain from sales of assets
$94,948,593
Net income from fundraising events
-$1,803,786
Net income from gaming
$26,475
Other revenue
$38,523,989

Expenses

Grants and similar amounts paid
$101,223,693
Compensation of officers, directors and key employees
$13,818,314
Other salaries and wages
$654,299,492
Salaries, compensation and benefits (total)
$853,703,548
Professional fundraising fees
$456,941
Legal fees
$2,842,662
Accounting fees
$1,195,124
Occupancy
$39,484,850
Travel
$6,640,359
Depreciation
$75,810,261
Program services (functional)
$2,103,416,126
Management and general (functional)
$273,626,775
Fundraising (functional)
$28,942,816

Balance sheet and other

Total assets, start of year
$3,446,635,074
Total assets, end of year
$3,600,753,073
Total liabilities, end of year
$2,033,708,861
Net assets, end of year
$1,567,044,212
Land, buildings and equipment
$1,134,850,183
Publicly traded securities
$788,749,976
Net assets without donor restrictions
$807,322,505
Net assets with donor restrictions
$759,721,707
Gross receipts
$3,466,212,478
Employees
7,088
Volunteers
719
Year formed
1998
State of legal domicile
WA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended June 30, 2025, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
THOMAS J LYNCH MDPresident & Director
Trustee or director, Officer
55$2,232,376$366,037
NICOLE C ROBINSON PhDVP & Chief Operating Officer
Officer
55$1,587,507$168,028
SARA HURVITZ MDSVP & Director, Clinical Research
Highest-paid employee
55$1,271,572$197,194
NANCY DAVIDSON MDEVP, Clinical Affairs
Trustee or director
55$1,250,784$173,381
DAVID BROWDYVP & Chief Financial Officer
Officer
54$1,186,790$171,147
TOM PURCELL MDVP & Chief Medical Officer
Key employee
55$1,150,671$153,743
BRUCE E CLURMAN MD PHDEVP, Chief Sci. Officer & Deputy Director
Key employee
55$1,019,199$161,693
STEVEN HAYDONFormer Officer
Former
55$1,045,174$14,579
ERIC C HOLLAND MD PHDSVP & Director, Human Biology
Highest-paid employee
55$860,361$149,485
Nida ShekhaniVP & Chief Strategy Officer
Key employee
55$805,373$160,154
FREDERICK APPELBAUM MDExecutive Vice President
Key employee
55$811,307$147,590
KELLY O'BRIENVP & Chief Philanthropy Officer
Key employee
55$786,916$147,090
GEOFFREY HILL MDSVP & Director, Translational Sci
Highest-paid employee
55$772,025$144,809
Warren T Phipps MDAssociate Professor
Highest-paid employee
54$692,880$111,646
JODI BURKEVP, Human Resources
Highest-paid employee
55$615,767$142,421
32 more people on this return
NameTitleHours / weekCompensationOther / benefits
GERIANNE SANDSCorporate Secretary, VP & General Counsel
Officer
55$539,962$102,057
STEPHANIE MAYSFormer Officer
Former
55$463,223$69,661
Denene Prophet-Williams MBA MLA BSNVP & Chief Nursing Officer - Beg 4/1/24
Key employee
55$471,417$58,935
BRITTANY MCCREERY MDFormer Key Employee
Former
55$373,473$112,239
RICHARD LAFRANCEFormer Key Employee
Former
55$328,414$72,151
CINDY GIST MHAFormer Key Employee
Former
55$312,580$83,751
CHRIS BUNDESMANNCorporate Controller
Officer
54$317,546$53,455
NICKI NGUYEN-COLVINFormer Key Employee
Former
55$291,603$60,432
HERBERT L BONE IIICorporate Treasurer
Officer
55$284,408$57,701
TIMOTHY EHLINGFormer Key Employee
Former
55$262,659$61,988
DANIEL MARKUSFormer Key Employee
Former
55$284,932$35,739
MICHELLE HALLFormer Key Employee
Former
55$265,346$52,496
GANSUVD BALGANSURENFormer Key Employee
Former
55$243,187$49,924
PAUL HELMUTHFormer Key Employee
Former
55$251,338$35,300
MATTHEW MCSWEYNFormer Key Employee
Former
55$224,380$45,544
CHAD HOGGARDFormer Key Employee
Former
55$238,527$29,956
ANDREW JACKSONFormer Key Employee
Former
55$165,723$33,211
Julie NordstromSecretary
Trustee or director, Officer
4$0$0
Leigh MorganChair
Trustee or director, Officer
4$0$0
Pete ShimerTreasurer
Trustee or director, Officer
4$0$0
Richard AndersonVice-Chair
Trustee or director, Officer
4$0$0
Bradley SimmonsDirector
Trustee or director
2$0$0
Cheryl M ScottDirector
Trustee or director
2$0$0
Eduardao PenalverDirector
Trustee or director
2$0$0
JAMES LICODirector - Beg 6/18/25
Trustee or director
2$0$0
JEFF YURCISINDIRECTOR - Beg 1/29/25
Trustee or director
2$0$0
Joanne HarrellDirector
Trustee or director
2$0$0
Kathy Surace-SmithDirector
Trustee or director
2$0$0
MICHELLE SEITZDirector
Trustee or director
2$0$0
Sean BoyleDirector
Trustee or director
2$0$0
Stephen GrahamDirector
Trustee or director
2$0$0
Timothy H Dellit MDDirector
Trustee or director
2$0$0
990 for the year ended June 30, 2024: 47 people
NameTitleHours / weekCompensationOther / benefits
THOMAS J LYNCH MDPRESIDENT & DIRECTOR
Trustee or director, Officer
55$2,028,077$364,136
NANCY DAVIDSON MDEVP, CLINICAL AFFAIRS
Trustee or director
55$1,198,547$159,901
NICOLE C ROBINSON PHDVP & COO
Officer
55$1,153,027$162,054
DAVID BROWDYVP & CFO
Officer
54$1,115,822$171,675
SARA HURVITZ MDSVP & DIRECTOR, CLINICAL RESEARCH
Highest-paid employee
55$1,057,788$58,156
BRUCE E CLURMAN MD PHDEVP, CHIEF SCI. OFFICER & DEPUTY DIRECTOR
Key employee
55$961,057$147,503
ERIC C HOLLAND MD PHDSVP & DIRECTOR, HUMAN BIOLOGY
Highest-paid employee
55$803,616$144,143
FREDERICK APPELBAUM MDEXECUTIVE VICE PRESIDENT
Key employee
55$771,543$141,975
STEVEN HAYDONVP & GENERAL COUNSEL(THRU 2/24)
Officer
55$812,745$73,528
GEOFFREY HILL MDSVP & DIRECTOR, TRANSLATIONAL SCI
Highest-paid employee
55$718,444$137,250
KELLY PATRICKVP & CIO
Highest-paid employee
55$761,873$56,627
TOM PURCELL MDVP & CHIEF MEDICAL OFFICER
Key employee
55$661,932$137,970
JODI BURKEVP, HUMAN RESOURCES
Highest-paid employee
55$640,821$132,867
KELLY O'BRIENVP & CHIEF PHILANTHROPY OFFICER
Key employee
55$621,488$136,478
THERESA MCDONNELL DNPVP & CHIEF NURSING OFFICER(THRU 9/23)
Key employee
55$608,583$63,093
STEPHANIE MAYSFORMER OFFICER
Former
55$512,712$68,204
CINDY GIST MHAFORMER KEY EMPLOYEE
Former
55$354,803$87,573
CHAD HOGGARDFORMER KEY EMPLOYEE
Former
55$368,825$70,387
GERIANNE SANDSCORP SEC., VP&GEN. COUNSEL(BEG 2/24)
Officer
55$365,941$62,781
BRITTANY MCCREERY MDFORMER KEY EMPLOYEE
Former
55$320,868$107,709
NICKI NGUYEN-COLVINFORMER KEY EMPLOYEE
Former
55$327,282$64,843
RICHARD LAFRANCEFORMER KEY EMPLOYEE
Former
55$276,203$65,984
CHRIS BUNDESMANNCORPORATE CONTROLLER
Officer
54$288,955$50,244
HERBERT L BONE IIICORPORATE TREASURER
Officer
55$258,649$57,304
TIMOTHY EHLINGFORMER KEY EMPLOYEE
Former
55$252,017$60,849
MICHELLE HALLFORMER KEY EMPLOYEE
Former
55$258,875$52,093
DANIEL MARKUSFORMER KEY EMPLOYEE
Former
55$270,742$33,752
GANSUVD BALGANSURENFORMER KEY EMPLOYEE
Former
55$233,728$49,429
PAUL HELMUTHFORMER KEY EMPLOYEE
Former
55$240,299$34,345
MATTHEW MCSWEYNFORMER KEY EMPLOYEE
Former
55$227,577$45,212
CARILLA WALLINFORMER KEY EMPLOYEE
Former
55$216,323$49,736
TAMI DEEBFORMER KEY EMPLOYEE
Former
55$205,480$22,814
ANDREW JACKSONFORMER KEY EMPLOYEE
Former
55$163,218$31,001
LEIGH MORGANCHAIR
Trustee or director, Officer
4$0$0
RICHARD ANDERSONVICE-CHAIR(FROM 1/24)
Trustee or director, Officer
4$0$0
SEAN BOYLEVICE-CHAIR(THRU 1/24), DIRECTOR
Trustee or director, Officer
2$0$0
KRISTIANNE BLAKETREASURER
Trustee or director, Officer
4$0$0
JULIE NORDSTROMSECRETARY
Trustee or director, Officer
4$0$0
BRADLEY SIMMONSDIRECTOR(FROM 8/23)
Trustee or director
2$0$0
CHERYL M SCOTTDIRECTOR (BEG 4/24)
Trustee or director
2$0$0
CYNTHIA DOLDDIRECTOR(THRU 8/23)
Trustee or director
2$0$0
EDUARDO PENALVERDIRECTOR
Trustee or director
2$0$0
JOANNE HARRELLDIRECTOR
Trustee or director
2$0$0
KATHY SURACE-SMITHDIRECTOR
Trustee or director
2$0$0
PETE SHIMERDIRECTOR
Trustee or director
2$0$0
STEPHEN GRAHAMDIRECTOR
Trustee or director
2$0$0
TIMOTHY H DELLIT MDDIRECTOR
Trustee or director
2$0$0
990 for the year ended June 30, 2023: 43 people
NameTitleHours / weekCompensationOther / benefits
THOMAS LYNCHPRESIDENT & DIRECTOR
Trustee or director, Officer
55$1,877,400$85,620
NANCY DAVIDSON MDEVP CLINICAL AFFAIRS
Trustee or director
55$1,545,412$50,466
AARON CRANEFORMER OFF/CHIEF CLINICAL OP
Former
55$1,546,465$44,521
NICOLE C ROBINSONVP & DEPUTY COO
Officer
55$960,946$76,800
DAVID HARLAN BROWDYVP & CHIEF FINANCIAL OFFICER
Officer
55$902,580$66,120
BRUCE E CLURMANEXEC VP & DEPUTY DIR, FHCC
Highest-paid employee
40$842,773$60,954
TOM PURCELLVP & CHIEF MEDICAL OFFICER
Key employee
55$825,503$59,288
ERIC C HOLLANDNE MDO STAFF
Highest-paid employee
40$775,665$75,792
FREDERICK R APPELBAUMEXEC VP & DEPUTY DIR, EXT AFFR
Highest-paid employee
40$749,598$59,552
STEVEN HAYDONVP, GENERAL COUNSEL
Officer
55$661,179$80,452
STEVE STADUMEXEC VP & COOO
Highest-paid employee
20$592,831$80,406
THERESA MCDONELLVP & CHIEF NURSING OFFICER
Key employee
55$595,290$63,824
KELLY PATRICKFORMER OFF/VP
Highest-paid employee
55$603,285$52,191
KELLY O'BRIENVP PHILANTHROPY
Key employee
55$573,513$60,488
STEPHANIE MAYSFORMER OFF/AVP & DEPUTY GEN.
Former
55$475,128$66,941
BRITTANY MCCREERYFORMER KE/VP
Former
55$330,621$56,206
RICHARD LAFRANCEFORMER KE/DIR. PHARMACY
Former
55$307,586$57,109
CHRIS BUNDESMANNCORPORATE CONTROLLER
Officer
55$311,642$46,225
CHAD HOGGARDFORMER KE/CHIEF INFO SEC. OFF
Former
55$294,876$56,680
STEVEN HUEBNERFORMER OFF/CFO
Former
55$340,470$0
NICKI NGUYEN-COLVINFORMER KE/DIR. STRATEGY
Former
55$281,392$53,337
CINDY GISTFORMER KE/VP, PATIENT SVCS
Former
55$286,843$47,859
HERBERT L BONE IIICORPORATE TREASURER
Officer
55$280,088$52,047
DANIEL MARKUSFORMER KE/DIR. SUPPLY CHAIN
Former
55$295,010$28,063
TIMOTHY EHLINGFORMER KE/DIR. NURSING
Former
55$253,545$50,073
MATTHEW MCSWEYNFORMER KE/DIR. INFRA & OPS.
Former
55$250,600$43,190
MICHELLE HALLFORMER KE/DIR. IT OPS
Former
55$248,584$44,064
PAUL HELMUTHFORMER KE/DIR. CLIN BUS OPS
Former
55$241,622$31,470
GANSUVD BALGANSURENFORMER KE/DIR. CI LABS
Former
55$224,007$41,634
CARILLA WALLINFORMER KE/DIR. STRAT OUTREACH
Former
55$209,028$46,000
ANDREW JACKSONFORMER KE/ASSOC. DIR. ENTER.
Former
55$191,839$32,882
KATHY SURACE-SMITHCHAIR
Trustee or director, Officer
4$0$0
LEIGH MORGANVICE CHAIR
Trustee or director, Officer
4$0$0
SEAN BOYLETREASURER
Trustee or director, Officer
4$0$0
JULIE NORDSTROMSECRETARY
Trustee or director, Officer
2$0$0
KRISTIANNE BLAKEDIRECTOR
Trustee or director
2$0$0
STEPHEN GRAHAMDIRECTOR
Trustee or director
2$0$0
JOANNE HARRELLDIRECTOR
Trustee or director
2$0$0
CYNTHIA DOLDDIRECTOR
Trustee or director
2$0$0
EDUARDAO PENALVERDIRECTOR
Trustee or director
2$0$0
TIMOTHY DELLITDIRECTOR
Trustee or director
2$0$0
JEREMY JAECHDIRECTOR (THRU 03/23)
Trustee or director
2$0$0
LISA BRANDENBURGEX-OFFICIO DIRECTOR (THRU 9/22)
Trustee or director
2$0$0

Address and contacts

Address (IRS master file)
1100 FAIRVIEW AVE N, SEATTLE, WA 98109-4433
Principal officer (990 for 2024)
Dr Thomas Lynch JR, 1100 Fairview Avenue North, Seatle, WA 981091024
Signed the 990
Dr Thomas Lynch JR, President and Director
Phone
(206) 606-1000
Return prepared by
CLARK NUBER PS

Mission

FRED HUTCH CANCER CENTER ("FRED HUTCH") UNITES INNOVATIVE RESEARCH AND COMPASSIONATE CARE TO PREVENT AND ELIMINATE CANCER AND INFECTIOUS DISEASE. CONTINUED ON SCHEDULE O

990 for the year ended June 30, 2025

Program accomplishments

  • Clinical Program: FRED HUTCH'S FOCUS IS SPEEDING THE TRANSFER OF NEW DIAGNOSTIC AND TREATMENT TECHNIQUES FROM THE RESEARCH SETTING TO PATIENT CARE. THE HIGHLY INTEGRATED APPROACH TO CANCER RESEARCH AND TREATMENT SUPPORTS THE FLOW OF SCIENTIFIC INFORMATION FROM RESEARCHERS AND THE LAB TO CLINICIANS AND PATIENTS, THEREBY ACCELERATING THE DEVELOPMENT OF NEW KNOWLEDGE AND TREATMENT FOR VARIOUS CANCERS. DURING THE FISCAL YEAR, FRED HUTCH HAD 4,395 PATIENT DAYS, 77,331 OUTPATIENT CLINIC VISITS, 111,884 INFUSION HOURS, 13,417 RADIATION ONCOLOGY TREATMENTS, AND PERFORMED 59,223 IMAGING SCANS. OUR CARE TEAMS SERVED MORE THAN 72,000 PATIENTS IN THE FISCAL YEAR. AS PART OF FRED HUTCH'S COMMITMENT TO ADVANCING THE STANDARD OF CANCER CARE, WE OFFER MANY EDUCATIONAL OPPORTUNITIES FOR HEALTH CARE PROFESSIONALS OF ALL KINDS SEEKING SPECIALIZED KNOWLEDGE IN ONCOLOGY SETTINGS TO EARN CONTINUING EDUCATION CREDITS. FRED HUTCH IS DESIGNATED AS AN INSTRUCTIONAL SITE FOR BACHELOR AND ADVANCED DEGREE CANDIDATES FROM SEVERAL INSTITUTIONS AROUND THE PUGET SOUND AREA. FRED HUTCH EDUCATION AND TRAINING OPPORTUNITIES ARE AVAILABLE TO PEOPLE LIKE PROVIDERS AND NURSES, PATIENTS AND CAREGIVERS, FACULTY, GRADUATE STUDENTS AND POSTDOCTORAL AND MEDICAL FELLOWS. THERE ARE ALSO INTERNSHIPS AND PROGRAMS FOR SECONDARY SCHOOL TEACHERS, AS WELL AS HIGH SCHOOL AND UNDERGRADUATE STUDENTS. IN FY25, THERE WERE APPROXIMATELY 300 TRAINEES AT FRED HUTCH INCLUDING GRADUATE STUDENTS AND POSTDOCTORAL AND CLINICAL FELLOWS. FRED HUTCH OFFERS TEMPORARY MEDICAL LODGING FACILITIES FOR PATIENTS AND FAMILIES WHILE THEY RECEIVE ACTIVE TREATMENT AT FRED HUTCH. THEIR TWO AVAILABLE FACILITIES ARE THE BEHNKE FAMILY HOUSE AND THE PETE GROSS HOUSE. LODGING OPTIONS CAN ACCOMMODATE EITHER SHORT-TERM OR LONG-TERM (30 NIGHT MINIMUM) STAYS AS MEDICALLY NECESSARY TO KEEP PATIENTS CLOSE DURING THEIR TREATMENT AT FRED HUTCH. FRED HUTCH PROVIDES TRANSPORTATION TO AND FROM BOTH FACILITIES THROUGH THE SOUTH LAKE UNION CLINIC.
    Expenses $1,318,857,503 · grants $1,010,128 · revenue $1,632,271,113
  • RESEARCH PROGRAM: FRED HUTCH RESEARCHERS HAVE ADVANCED HUMAN UNDERSTANDING ACROSS A WIDE RANGE OF AREAS, REFLECTING THE BREADTH AND DEPTH OF EXPERTISE AT FRED HUTCH THAT ALLOWS US TO DEVELOP POTENTIAL CURES FOR CANCER AND INFECTIOUS DISEASES. OUR TEAMS ALSO APPLIED ARTIFICIAL INTELLIGENCE AND OTHER NOVEL APPROACHES TO MATCH EXISTING TREATMENTS TO DIAGNOSES OR BETTER UNDERSTAND HOW CANCER MAY BE IMPACTING INDIVIDUALS IN DIFFERENT WAYS. FRED HUTCH SCIENTISTS ARE PRODUCING SOME OF THE MOST IMPORTANT BREAKTHROUGHS IN THE PREVENTION, EARLY DETECTION AND TREATMENT OF CANCER, HIV AND OTHER DISEASES. OUR SCIENTISTS STUDY EVERY ASPECT OF THE DISEASE PROCESS TO UNCOVER FACTORS THAT INFLUENCE DISEASE RISK AND PROGRESSION. FRED HUTCH HAS BEEN HOME TO THREE NOBEL LAUREATES, AND OUR FACULTY INCLUDES MORE THAN 400 RENOWNED RESEARCHERS WHO COLLABORATE WITH COLLEAGUES ACROSS THE GLOBE AND MENTOR THE NEXT GENERATION OF SCIENTIFIC INNOVATORS. OUR SCIENTISTS CONDUCT RESEARCH ON AND DEVELOP THERAPIES FOR MANY CANCERS - INCLUDING BLOOD CANCERS AND SOLID TUMORS - AS WELL AS FOR HIV AND OTHER NONMALIGNANT DISEASES. THEY STUDY THE DISEASE PROCESS FROM EVERY ANGLE, FROM THE MOST BASIC MOLECULAR AND CELLULAR LEVELS TO THE POPULATION LEVEL. THEIR GOALS ARE TO UNCOVER THE FACTORS THAT INFLUENCE A PERSON'S LIKELIHOOD OF DEVELOPING AND SURVIVING A DISEASE AND USE THIS KNOWLEDGE TO REDUCE RISK, SAVE LIVES AND IMPROVE QUALITY OF LIFE. FRED HUTCH RESEARCHERS ARE EXPERTS IN UNDERSTANDING THE DEVELOPMENT OF BLOOD AND SOLID TUMOR CANCERS AS WELL AS IDENTIFYING NEW WAYS TO DIAGNOSE, PREVENT AND TREAT CANCERS. THEIR RESEARCH INCLUDES A WIDE AREA OF TOPICS THAT AFFECT CANCER AND INFECTIOUS DISEASES SUCH AS BEHAVIORAL RESEARCH, CELL AND GENE THERAPY, DATA SCIENCE, DISEASE PREVENTION, HEALTH ECONOMICS, VIROLOGY, AND MORE. IN FY25, FRED HUTCH RESEARCHERS PUBLISHED 1,284 RESEARCH ARTICLES AND 44 PATENTS WERE GRANTED TO FRED HUTCH. FRED HUTCH RESEARCH PROGRAMS INTEGRATE THE LATEST IN COMPUTATIONAL, LABORATORY AND PATIENT-ORIENTED CLINICAL RESEARCH METHODS TO BETTER UNDERSTAND THE MECHANISMS THAT DRIVE CANCER AND OTHER HUMAN DISEASES. OUR RESEARCHERS ARE CONTINUALLY DEVELOPING NEW THERAPEUTIC APPROACHES AND THEY DEVELOP AND LEAD CLINICAL TRIALS THAT HELP MOVE LABORATORY DISCOVERIES INTO NEW TREATMENT OPTIONS FOR PATIENTS. OUR DISCOVERIES, WHICH INCLUDE PROVING THAT BONE MARROW TRANSPLANTATION CAN CURE LEUKEMIAS AND OTHER BLOOD CANCERS, HAVE SAVED MORE THAN A MILLION LIVES WORLDWIDE.
    Expenses $784,558,623 · grants $100,213,565 · revenue $18,051,057

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025June 30, 2026November 16, 2026Not due yet
2024June 30, 2025November 17, 2025990 on file
2023June 30, 2024November 15, 2024990 on file

IRS record

EIN
91-1935159
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Hospital or medical research organization
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2000
Accounting year ends
June
Files
Form 990 or 990-EZ
Category (NTEE)
Health care (E240)
Assets (IRS master file)
$3,600,753,073
Income (IRS master file)
$3,466,212,478

Filing history

FormYear endedRevenueExpensesAssetsReturn
990June 2025$2,532,392,907$2,405,985,717$3,600,753,073IRS
990-TJune 2025–––IRS
990June 2024$2,027,046,671$2,064,743,953$3,453,149,919IRS
990-TJune 2024–––IRS
990June 2023$2,322,795,971$1,951,660,593$3,407,176,412XML
990-TJune 2023–––IRS
990June 2022$1,283,961,922$1,134,529,429$2,999,831,201IRS
990June 2021–––IRS
990June 2020–––IRS
990June 2019–––IRS
990June 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 91-1935159).

Questions about FRED HUTCHINSON CANCER CENTER

What is the EIN of FRED HUTCHINSON CANCER CENTER?
The employer identification number (EIN) of FRED HUTCHINSON CANCER CENTER is 91-1935159.
Is FRED HUTCHINSON CANCER CENTER tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2000.
Are donations to FRED HUTCHINSON CANCER CENTER tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does FRED HUTCHINSON CANCER CENTER file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of FRED HUTCHINSON CANCER CENTER due?
The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did FRED HUTCHINSON CANCER CENTER last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended June 2025.
Who is the principal officer of FRED HUTCHINSON CANCER CENTER?
The 990 for the year ended June 30, 2025 names Dr Thomas Lynch JR.
Who are the officers and directors of FRED HUTCHINSON CANCER CENTER?
The 990 for the year ended June 30, 2025 lists 47 people; 32 received compensation from the organization, the highest $2,232,376 (THOMAS J LYNCH MD, President & Director).
How much revenue does FRED HUTCHINSON CANCER CENTER have?
On its 990 for the year ended June 30, 2025 it reported revenue of $2,532,392,907, expenses of $2,405,985,717 and total assets of $3,600,753,073 at year end.

Other nonprofits in SEATTLE

All nonprofits in SEATTLE · Washington · Health care